JPRN-jRCT2071210104进行中（未招募）1 期
A Randomized, Double-blind, Placebo-controlled, Single-center, Single and Multiple Oral Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral BF2.649 (pitolisant hydrochloride) in Healthy Japanese Adult Subjects
Takuma Yonemura0 个研究点目标入组 28 人开始时间: 2021年12月26日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 45age old（—）
- 性别
- Male
入选标准
- •Healthy Japanese male volunteers aged 20 to 45 years
排除标准
- •1. Individuals with a history of drug allergy, food allergy, allergic rash, asthma, intolerance or hypersensitivity to some drugs, or photosensitivity
- •2. Having alcohol or drug dependence etc.
研究者
相似试验
已完成
1 期
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of VGT-309 in Healthy SubjectsCancerACTRN12620000948998Vergent Bioscience Australia, Pty Ltd46
已完成
不适用
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers.Diseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0000968iNtRON Biotechnology36
进行中（未招募）
1 期
A Study of JNJ-75105186 in Healthy Japanese and Chinese ParticipantsHealthyJPRN-jRCT2071210082akano Masayoshi32
已完成
不适用
A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of REC-3964 in Healthy SubjectsNL-OMON53684Recursion Pharmaceuticals, Inc.106
进行中（未招募）
1 期
Safety, tolerability, pharmacokinetics and pharmacodynamics of CBP-201 in healthy volunteersAtopic DermatitisACTRN12618000756224Connect Biopharma Australia Pty Ltd40